The DOI matches its Crossref record; 250 of the 251 references it cites were found in a registry or an index.
The Safety, Tolerability and Risks Associated with the Use of Newer Generation Antidepressant Drugs: A Critical Review of the Literature
Abstract
Newer generation antidepressant drugs (ADs) are widely used as the first line of treatment for major depressive disorders and are considered to be safer than tricyclic agents. In this critical review, we evaluated the literature on adverse events, tolerability and safety of selective serotonin reuptake inhibitors, serotonin noradrenaline reuptake inhibitors, bupropion, mirtazapine, trazodone, agomelatine, vilazodone, levomilnacipran and vortioxetine. Several side effects are transient and may disappear after a few weeks following treatment initiation, but potentially serious adverse events may persist or ensue later. They encompass gastrointestinal symptoms (nausea, diarrhea, gastric bleeding, dyspepsia), hepatotoxicity, weight gain and metabolic abnormalities, cardiovascular disturbances (heart rate, QT interval prolongation, hypertension, orthostatic hypotension), genitourinary symptoms (urinary retention, incontinence), sexual dysfunction, hyponatremia, osteoporosis and risk of fractures, bleeding, central nervous system disturbances (lowering of seizure threshold, extrapyramidal side effects, cognitive disturbances), sweating, sleep disturbances, affective disturbances (apathy, switches, paradoxical effects), ophthalmic manifestations (glaucoma, cataract) and hyperprolactinemia. At times, such adverse events may persist after drug discontinuation, yielding iatrogenic comorbidity. Other areas of concern involve suicidality, safety in overdose, discontinuation syndromes, risks during pregnancy and breast feeding, as well as risk of malignancies. Thus, the rational selection of ADs should consider the potential benefits and risks, likelihood of responsiveness to the treatment option and vulnerability to adverse events. The findings of this review should alert the physician to carefully review the appropriateness of AD prescription on an individual basis and to consider alternative treatments if available.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Common side effects include nausea, vomiting, diarrhea, headache, insomnia, and agitation (104).”
From The 2023 Impact of Inflammatory Bowel Disease in Canada: Mental Health and Inflammatory Bowel Disease (2023) · cites this paper as [104]
In the citing paper
“Another drawback of long-term antidepressant treatment is concerned with the serious and bothersome side effects that may ensue with SSRI and SNRI, such as high rates of sexual dysfunction, bleeding (in particular gastrointestinal), weight gain, risk of fracture and osteoporosis, and hyponatremia.73”
From May antidepressant drugs worsen the conditions they are supposed to treat? The clinical foundations of the oppositional model of tolerance (2020) · cites this paper as [73]
In the citing paper
“Examples are switching from unipolar to bipolar course with antidepressant drugs [6,31] and supersensitivity psychosis, the onset of psychotic symptoms and co-occurring movement disorder with antipsychotic medications [4].”
From Iatrogenic Factors in Psychopathology (2019) · cites this paper as [6]
In the citing paper
“For instance, several side effects of antidepressants are transient and may disappear after a few weeks following treatment initiation, but potentially serious adverse events may persist or ensue later.”
From Iatrogenic Factors in Psychopathology (2019) · cites this paper as [6]
In the citing paper
“Since gastric symptomatology did not follow the somatic patterns typical of anxiety disturbances, venlafaxine was also suspected as a iatrogenic cause [6].”
From Iatrogenic Factors in Psychopathology (2019) · cites this paper as [6]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
1 retracted
Barbui, C., Hotopf, M. H., Freemantle, N., Boynton, J. R., Churchill, R. C., Eccles, M., Geddes, J. R., Hardy, R., Lewis, G., & Mason, J. M. (2000) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002791 · Cited by 87
RetractedProjections of Global Mortality and Burden of Disease from 2002 to 2030
Mathers, C. D., & Loncar, D. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030442 · Cited by 11,386
Suicide and suicidal behaviour
Turecki, G., & Brent, D. A. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00234-2 · Cited by 2,338
Boyer, E. W., & Shannon, M. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041867 · Cited by 1,821
Prevalence of Depression During Pregnancy: Systematic Review
Bennett, H. A., Einarson, A., Taddio, A., Koren, G., & Einarson, T. R. (2004) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000116689.75396.5f · Cited by 1,725
Cipriani, A., Furukawa, T. A., Salanti, G., Geddes, J. R., Higgins, J. P., Churchill, R., Watanabe, N., Nakagawa, A., Omori, I. M., McGuire, H., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60046-5 · Cited by 1,654
Apathy and the Functional Anatomy of the Prefrontal Cortex–Basal Ganglia Circuits
Levy, R., & Dubois, B. (2006) · Cerebral Cortex · doi:10.1093/cercor/bhj043 · Cited by 1,285
Anderson, I. M. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00092-0 · Cited by 940
Kessler, R. C. (2012) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2011.11.005 · Cited by 871
Antidepressant use and risk of adverse outcomes in older people: population based cohort study
Coupland, C., Dhiman, P., Morriss, R., Arthur, A., Barton, G., & Hippisley-Cox, J. (2011) · BMJ · doi:10.1136/bmj.d4551 · Cited by 833
Research works printed but not linked: 1
- 10.1345/aph.1A254 · doi:10.1345/aph.1a254 · Paper page
Cited by
Firth, J., Siddiqi, N., Koyanagi, A., Siskind, D., Rosenbaum, S., Galletly, C., Allan, S., Caneo, C., Carney, R., Carvalho, A. F., et al. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30132-4 · Cited by 1,531
Self-citationMcCarron, R. M., Shapiro, B., Rawles, J., & Luo, J. (2021) · Annals of Internal Medicine · doi:10.7326/aitc202105180 · Cited by 492
Buckman, J. E. J., Underwood, A., Clarke, K., Saunders, R., Hollon, S. D., Fearon, P., & Pilling, S. (2018) · Clinical Psychology Review · doi:10.1016/j.cpr.2018.07.005 · Cited by 398
Depression in cancer: The many biobehavioral pathways driving tumor progression
Bortolato, B., Hyphantis, T. N., Valpione, S., Perini, G., Maes, M., Morris, G., Kubera, M., Köhler, C. A., Fernandes, B. S., Stubbs, B., et al. (2017) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2016.11.004 · Cited by 375
Self-citationKietaibl, S., Ahmed, A., Afshari, A., Albaladejo, P., Aldecoa, C., Barauskas, G., De Robertis, E., Faraoni, D., Filipescu, D. C., Fries, D., et al. (2023) · European Journal of Anaesthesiology · doi:10.1097/eja.0000000000001803 · Cited by 345
Köhler, C. A., Evangelou, E., Stubbs, B., Solmi, M., Veronese, N., Belbasis, L., Bortolato, B., Melo, M. C. A., Coelho, C. A., Fernandes, B. S., et al. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2018.05.020 · Cited by 302
Self-citationCurrent Psychosomatic Practice
Fava, G. A., Cosci, F., & Sonino, N. (2017) · Psychotherapy and Psychosomatics · doi:10.1159/000448856 · Cited by 302
Self-citationAddressing the Side Effects of Contemporary Antidepressant Drugs: A Comprehensive Review
Wang, S.-M., Han, C., Bahk, W.-M., Lee, S.-J., Patkar, A. A., Masand, P. S., & Pae, C.-U. (2018) · Chonnam Medical Journal · doi:10.4068/cmj.2018.54.2.101 · Cited by 299
Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications
Cosci, F., & Chouinard, G. (2020) · Psychotherapy and Psychosomatics · doi:10.1159/000506868 · Cited by 265
Dandekar, M. P., Fenoy, A. J., Carvalho, A. F., Soares, J. C., & Quevedo, J. (2018) · Molecular Psychiatry · doi:10.1038/mp.2018.2 · Cited by 266
Self-citationRazza, L. B., Palumbo, P., Moffa, A. H., Carvalho, A. F., Solmi, M., Loo, C. K., & Brunoni, A. R. (2020) · Depression and Anxiety · doi:10.1002/da.23004 · Cited by 236
Self-citationAntidepressant‐induced sexual dysfunction
Rothmore, J. (2020) · Medical Journal of Australia · doi:10.5694/mja2.50522 · Cited by 229
Wong, J., Motulsky, A., Abrahamowicz, M., Eguale, T., Buckeridge, D. L., & Tamblyn, R. (2017) · BMJ · doi:10.1136/bmj.j603 · Cited by 221
Association of Antidepressant Use With Adverse Health Outcomes: A Systematic Umbrella Review
Dragioti, E., Solmi, M., Favaro, A., Fusar-Poli, P., Dazzan, P., Thompson, T., Stubbs, B., Firth, J., Fornaro, M., Tsartsalis, D., et al. (2019) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2019.2859 · Cited by 215
Self-citationMazereel, V., Detraux, J., Vancampfort, D., van Winkel, R., & De Hert, M. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.573479 · Cited by 205
Antidepressant Medications and Weight Change: A Narrative Review
Gill, H., Gill, B., El‐Halabi, S., Chen‐Li, D., Lipsitz, O., Rosenblat, J. D., Van Rheenen, T. E., Rodrigues, N. B., Mansur, R. B., Majeed, A., et al. (2020) · Obesity · doi:10.1002/oby.22969 · Cited by 193
Marx, W., Manger, S. H., Blencowe, M., Murray, G., Ho, F. Y.-Y., Lawn, S., Blumenthal, J. A., Schuch, F., Stubbs, B., Ruusunen, A., et al. (2023) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2022.2112074 · Cited by 179
Breeksema, J. J., Kuin, B. W., Kamphuis, J., van den Brink, W., Vermetten, E., & Schoevers, R. A. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811221116926 · Cited by 178
“Moreover, adverse drug reactions may lead to non-adherence and discontinuation of treatment (Carvalho et al., 2016), and unresolved and non-integrated difficult experiences may lead to persisting negative outcomes (Grof, 2001; Johnson et al.”
BackgroundMoffa, A. H., Martin, D., Alonzo, A., Bennabi, D., Blumberger, D. M., Benseñor, I. M., Daskalakis, Z., Fregni, F., Haffen, E., Lisanby, S. H., et al. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109836 · Cited by 171
Self-citationRazza, L. B., Moffa, A. H., Moreno, M. L., Carvalho, A. F., Padberg, F., Fregni, F., & Brunoni, A. R. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.10.016 · Cited by 172
Self-citationPrimary biliary cholangitis: Epidemiology, prognosis, and treatment
Trivella, J., John, B. V., & Levy, C. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000179 · Cited by 159
Zhang, W., Qu, W., Wang, H., & Yan, H. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01254-5 · Cited by 164
Li, Y.-F. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107494 · Cited by 169
Antidepressant Drugs Effects on Blood Pressure
Calvi, A., Fischetti, I., Verzicco, I., Murri, M. B., Zanetidou, S., Volpi, R., Coghi, P., Tedeschi, S., Amore, M., & Cabassi, A. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.704281 · Cited by 174
Galvão-Coelho, N. L., Marx, W., Gonzalez, M., Sinclair, J., de Manincor, M., Perkins, D., & Sarris, J. (2021) · Psychopharmacology · doi:10.1007/s00213-020-05719-1 · Cited by 137
Timmerby, N., Andersen, J. H., Søndergaard, S., Østergaard, S. D., & Bech, P. (2017) · Psychotherapy and Psychosomatics · doi:10.1159/000457131 · Cited by 134
Gastaldon, C., Raschi, E., Kane, J. M., Barbui, C., & Schoretsanitis, G. (2021) · Psychotherapy and Psychosomatics · doi:10.1159/000510703 · Cited by 134
Behlke, L. M., Lenze, E. J., & Carney, R. M. (2020) · CNS Drugs · doi:10.1007/s40263-020-00763-z · Cited by 135
Fish behavior: A promising model for aquatic toxicology research
Hong, X., & Zha, J. (2019) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2019.06.028 · Cited by 125
Speyer, H., Jakobsen, A. S., Westergaard, C., Nørgaard, H. C. B., Pisinger, C., Krogh, J., Hjorthøj, C., Nordentoft, M., Gluud, C., Correll, C. U., et al. (2019) · Psychotherapy and Psychosomatics · doi:10.1159/000502293 · Cited by 116
Sleep disturbance associated with the menopause
Maki, P. M., Panay, N., & Simon, J. A. (2024) · Menopause · doi:10.1097/gme.0000000000002386 · Cited by 102
Furukawa, T. A., Efthimiou, O., Weitz, E. S., Cipriani, A., Keller, M. B., Kocsis, J. H., Klein, D. N., Michalak, J., Salanti, G., Cuijpers, P., et al. (2018) · Psychotherapy and Psychosomatics · doi:10.1159/000489227 · Cited by 109
Juengst, S. B., Kumar, R. G., & Wagner, A. K. (2017) · Psychology Research and Behavior Management · doi:10.2147/prbm.s113264 · Cited by 102
“However, it is important to note that side effects of newer-generation antidepressant drugs often overlap with and may compound symptoms after TBI.(130) Thus, careful consideration should be given to the relative benefits and risks of using these pharmacological agents, particularly where little is known about how the…”
Roles of microglia in adult hippocampal neurogenesis in depression and their therapeutics
Fang, S., Wu, Z., Guo, Y., Zhu, W., Wan, C., Yuan, N., Chen, J., Hao, W., Mo, X., Guo, X., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1193053 · Cited by 117
Maslej, M. M., Bolker, B. M., Russell, M. J., Eaton, K., Durisko, Z., Hollon, S. D., Swanson, G. M., Thomson Jr., J. A., Mulsant, B. H., & Andrews, P. W. (2017) · Psychotherapy and Psychosomatics · doi:10.1159/000477940 · Cited by 98
Transcranial magnetic stimulation (TMS) for geriatric depression
Cappon, D., den Boer, T., Jordan, C., Yu, W., Metzger, E., & Pascual-Leone, A. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101531 · Cited by 97
Forest therapy can prevent and treat depression: Evidence from meta-analyses
Rosa, C. D., Larson, L. R., Collado, S., & Profice, C. C. (2020) · Urban forestry & urban greening · doi:10.1016/j.ufug.2020.126943 · Cited by 108
Tan, C., Qiao, M., Ma, Y., Luo, Y., Fang, J., & Yang, Y. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.05.048 · Cited by 100
Fava, G. A., Cosci, F., Guidi, J., & Tomba, E. (2017) · Depression and Anxiety · doi:10.1002/da.22629 · Cited by 95
Self-citationHengartner, M. P., & Plöderl, M. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00517 · Cited by 111
Fava, G. A., Guidi, J., Rafanelli, C., & Rickels, K. (2017) · Psychotherapy and Psychosomatics · doi:10.1159/000480038 · Cited by 93
Self-citationSchifano, F., Chiappini, S., Corkery, J., & Guirguis, A. (2018) · Brain Sciences · doi:10.3390/brainsci8040073 · Cited by 111
Mulugeta, A., Zhou, A., King, C. E., & Hyppönen, E. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0486-1 · Cited by 106
Solmi, M., Miola, A., Croatto, G., Pigato, G., Favaro, A., Fornaro, M., Berk, M., Smith, L., Quevedo, J., Maes, M. H. J., et al. (2020) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2020-0935 · Cited by 118
Self-citationEffect of Forest Therapy on Depression and Anxiety: A Systematic Review and Meta-Analysis
Yeon, P., Jeon, J. Y., Jung, M.-S., Min, G.-M., Kim, G.-Y., Han, K.-M., Shin, M., Jo, S.-H., Kim, J.-G., & Shin, W.-S. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182312685 · Cited by 98
Meta-Analysis of the Risk of Subsequent Mood Episodes in Bipolar Disorder
Raduà, J., Grunze, H., & Amann, B. L. (2017) · Psychotherapy and Psychosomatics · doi:10.1159/000449417 · Cited by 94
Zhang, Z., Zhang, H., Xie, C., Zhang, M., Shi, Y., Song, R., Lu, X., Zhang, H., Li, K., Wang, B., et al. (2020) · Science China Life Sciences · doi:10.1007/s11427-020-1730-5 · Cited by 88
Kasper, S. F., Cubała, W. J., Fagiolini, A. M., Ramos‐Quiroga, J. A., Souery, D., & Young, A. H. (2020) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2020.1836399 · Cited by 93
Fava, G. A. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320970325 · Cited by 84
Self-citationAhmad, M. H., Rizvi, M. M. A., Fatima, M., & Mondal, A. C. (2020) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2020.111093 · Cited by 89
Iatrogenic Factors in Psychopathology
Fava, G. A., & Rafanelli, C. (2019) · Psychotherapy and Psychosomatics · doi:10.1159/000500151 · Cited by 82
Self-citationSaunders, R., Buckman, J. E. J., Stott, J., Leibowitz, J., Aguirre, E., John, A., Lewis, G., Cape, J., & Pilling, S. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.06.084 · Cited by 81
Fornaro, M., Anastasia, A., Novello, S., Fusco, A., Pariano, R., De Berardis, D., Solmi, M., Veronese, N., Stubbs, B., Vieta, E., et al. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2018.10.025 · Cited by 80
Self-citationShen, C., Tang, Y., Gao, Y., Nie, K., Wang, H., Su, H., Wang, Z., Lu, F., Huang, W., & Dong, H. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.865376 · Cited by 94
Benzodiazepines as a monotherapy in depressive disorders: a systematic review
Benasi, G., Guidi, J., Offidani, E., Balon, R., Rickels, K., & Fava, G. A. (2018) · Psychotherapy and Psychosomatics · doi:10.1159/000486696 · Cited by 79
Self-citationMoffa, A. H., Brunoni, A. R., Fregni, F., Palm, U., Padberg, F., Blumberger, D. M., Daskalakis, Z. J., Bennabi, D., Haffen, É., Alonzo, A., et al. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.06.021 · Cited by 80
Self-citationPharmacological Treatment of Generalised Anxiety Disorder: Current Practice and Future Directions
Fagan, H. A., & Baldwin, D. S. (2023) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2023.2211767 · Cited by 94
Hengartner, M. P., Schulthess, L., Sorensen, A., & Framer, A. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320980573 · Cited by 74
Canadian Guideline for the Clinical Management of High-Risk Drinking and Alcohol Use Disorder
Wood, E., Bright, J., Hsu, K., Goel, N., Ross, J. W. G., Hanson, A., Teed, R., Poulin, G., Denning, B., Corace, K., et al. (2023) · Canadian Medical Association Journal · doi:10.1503/cmaj.230715 · Cited by 74
“…the potential increase in alcohol consumption, lack of benefit in meta-analyses of randomized trials 34 and other risks (e.g., lowering seizure threshold), 42 we recommend against the use of SSRI antidepressants for the treatment of AUD, or for anxiety or depressive disorders concurrent with AUD.”
MethodHuang, J., Huang, W., Yi, J., Deng, Y., Li, R., Chen, J., Shi, J., Qiu, Y., Wang, T., Chen, X., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-43150-0 · Cited by 81
Framer, A. (2021) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125321991274 · Cited by 73
Gao, K., Farzi, A., Ke, X., Yu, Y., Chen, C., Chen, S., Yu, T., Wang, H., & Li, Y. (2021) · Food & Function · doi:10.1039/d1fo03723d · Cited by 86
Hengartner, M. P. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320921694 · Cited by 72
Esketamine: a glimmer of hope in treatment-resistant depression
Kaur, U., Pathak, B. K., Singh, A., & Chakrabarti, S. S. (2019) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-019-01084-z · Cited by 74
Understanding and Managing Withdrawal Syndromes After Discontinuation of Antidepressant Drugs
Fava, G. A., & Cosci, F. (2019) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.19com12794 · Cited by 69
Self-citationGlutamatergic Modulators for Major Depression from Theory to Clinical Use
McIntyre, R. S., & Jain, R. (2024) · CNS Drugs · doi:10.1007/s40263-024-01114-y · Cited by 69
Gueorguieva, R., Chekroud, A. M., & Krystal, J. H. (2017) · The Lancet Psychiatry · doi:10.1016/s2215-0366(17)30038-x · Cited by 67
De Diego-Adeliño, J., Crespo, J. M., Mora, F., Neyra, A., Iborra, P., Gutiérrez-Rojas, L., & Salonia, S. F. (2022) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2022.2019705 · Cited by 67
Fernandes, N., Prada, L., Rosa, M. M., Ferreira, J. J., Costa, J. N., Pinto, F. J., & Caldeira, D. (2020) · Clinical Research in Cardiology · doi:10.1007/s00392-020-01697-8 · Cited by 73
Huijbregts, K. M. L., Hoogendoorn, A. W., Slottje, P., van Balkom, A. J. L. M., & Batelaan, N. M. (2017) · Psychotherapy and Psychosomatics · doi:10.1159/000480456 · Cited by 68
Pharmacological management of post-stroke depression
Castilla‐Guerra, L., Moreno, M. D. C. F., Esparrago-Llorca, G., & Colmenero-Camacho, M. Á. (2019) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2020.1707666 · Cited by 74
Ladwig, K.-H., Baghai, T. C., Doyle, F., Hamer, M., Herrmann‐Lingen, C., Kunschitz, E., Lemogne, C., Beresnevaitė, M., Compare, A., von Känel, R., et al. (2022) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwac006 · Cited by 75
Bellet, M., Ahmad, F., Villanueva-Vázquez, R., Valdivia, C., Palomino-Doza, J., Ruiz, A. I., González, X., Adrover, E., Azaro, A., Valls-Margarit, M., et al. (2019) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835919833867 · Cited by 68
Rafanelli, C., Gostoli, S., Buzzichelli, S., Guidi, J., Sirri, L., Gallo, P., Marzola, E., Bergerone, S., Ferrari, G. M. D., Roncuzzi, R., et al. (2020) · Psychotherapy and Psychosomatics · doi:10.1159/000510006 · Cited by 65
Self-citationWolters, M., von der Haar, A., Baalmann, A.-K., Wellbrock, M., Heise, T. L., & Rach, S. (2021) · Nutrients · doi:10.3390/nu13041070 · Cited by 62
Barbuti, M., Pacchiarotti, I., Vieta, E., Azorin, J., Angst, J., Bowden, C. L., Mosolov, S. N., Young, A. H., & Perugi, G. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.05.035 · Cited by 63
Self-citationTrends in Antidepressant Use and Expenditure in Six Major Cities in China From 2013 to 2018
Yu, Z., Zhang, J., Zheng, Y., & Yu, L. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00551 · Cited by 67
Ma, H., Cai, M., & Wang, H. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.792960 · Cited by 59
“Common side effects mentioned in these survey studies include headache, nausea, weight gain, and sleepiness (17, 19).”
BackgroundGlutamatergic systems in neuropathic pain and emerging non-opioid therapies
Temmermand, R., Barrett, J. E., & Fontana, A. C. K. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106492 · Cited by 69
Interactions Between Antidepressants and Intestinal Microbiota
Xu, F., Xie, Q., Kuang, W., & Dong, Z. (2023) · Neurotherapeutics · doi:10.1007/s13311-023-01362-8 · Cited by 64
Central Neuromodulators in Irritable Bowel Syndrome: Why, How, and When
Hanna-Jairala, I., & Drossman, D. A. (2024) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000002800 · Cited by 77
Shafiee, A., Jafarabady, K., Seighali, N., Mohammadi, I., Firouzabadi, S. R., Abhari, F. S., & Bakhtiyari, M. (2024) · Nutrition Reviews · doi:10.1093/nutrit/nuae076 · Cited by 61
Esketamine Monotherapy in Adults With Treatment-Resistant Depression: A Randomized Clinical Trial
Janik, A., Qiu, X., Lane, R., Popova, V., Drevets, W. C., Canuso, C. M., Macaluso, M., Mattingly, G. W., Shelton, R. C., Zajecka, J. M., et al. (2025) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2025.1317 · Cited by 54
Apathy associated with antidepressant drugs: a systematic review
Masdrakis, V. G., Markianos, M., & Baldwin, D. S. (2023) · Acta Neuropsychiatrica · doi:10.1017/neu.2023.6 · Cited by 63
Hashimoto, K. (2024) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-024-01770-7 · Cited by 61
Clinical Pharmacopsychology: Conceptual Foundations and Emerging Tasks
Fava, G. A., Tomba, E., & Bech, P. (2017) · Psychotherapy and Psychosomatics · doi:10.1159/000458458 · Cited by 52
Self-citationHengartner, M. P. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00275 · Cited by 59
Ahmadpanah, M., Ramezanshams, F., Ghaleiha, A., Akhondzadeh, S., Bahmani, D. S., & Brand, S. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2019.112613 · Cited by 56
Association between hyperuricemia and metabolic syndrome in patients suffering from bipolar disorder
Chen, J., Chen, H., Feng, J., Zhang, L., Li, J., Li, R., Wang, S.-L., Wilson, I., Jones, A. L., Tan, Y., et al. (2018) · BMC Psychiatry · doi:10.1186/s12888-018-1952-z · Cited by 50
Tang, Y., Su, H., Nie, K., Wang, H., Gao, Y., Shen, C., Lu, F., & Dong, H. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.116012 · Cited by 52
Kuhlmann, S. L., Arolt, V., Haverkamp, W., Martus, P., Ströhle, A., Waltenberger, J. L., Rieckmann, N., & Müller‐Nordhorn, J. (2019) · Psychotherapy and Psychosomatics · doi:10.1159/000501502 · Cited by 57
Zhang, Y., Zheng, G., Fu, T., Hong, J., Li, F., Yao, X., Xue, W., & Zhu, F. (2020) · Physical Chemistry Chemical Physics · doi:10.1039/c9cp05764a · Cited by 48
Pharmacological management of depression: Japanese expert consensus
Sakurai, H., Uchida, H., Kato, M., Suzuki, T., Baba, H., Watanabe, K., Inada, K., Kikuchi, T., Katsuki, A., Kishida, I., et al. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.01.149 · Cited by 51
Petri, E., Bacci, O., Barbuti, M., Pacchiarotti, I., Azorin, J., Angst, J., Bowden, C. L., Mosolov, S. N., Vieta, E., Young, A. H., et al. (2017) · Bipolar Disorders · doi:10.1111/bdi.12519 · Cited by 52
Self-citationWoroń, J., Siwek, M., & Gorostowicz, A. (2018) · Psychiatria Polska · doi:10.12740/pp/onlinefirst/96286 · Cited by 54
Gupta, K., Gupta, R., Bhatia, M. S., Tripathi, A. K., & Gupta, L. K. (2017) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.963 · Cited by 54
Pharmacologic Treatment of Perinatal Depression
Kimmel, M., Cox, E., Schiller, C. E., Gettes, E., & Meltzer-Brody, S. E. (2018) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2018.04.007 · Cited by 50
Depression in the medically ill
Rosenblat, J. D., Kurdyak, P. A., Cosci, F., Berk, M., Maes, M. H. J., Brunoni, A. R., Li, M., Rodin, G., McIntyre, R. S., & Carvalho, A. F. (2019) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867419888576 · Cited by 54
Self-citationKong, W., Deng, H., Wan, J., Zhou, Y., Zhou, Y., Song, B., & Wang, X. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.580858 · Cited by 49
Wang, J., & Cosci, F. (2021) · Psychotherapy and Psychosomatics · doi:10.1159/000516031 · Cited by 47
Metadata
- Authors
- Carvalho, A. F., Sharma, M. S., Brunoni, A. R., Vieta, E., & Fava, G. A.
- Affiliations
- The University of Texas Health Science Center at Houston (US)
- Universidade de São Paulo (BR)
- Centro de Investigación Biomédica en Red de Salud Mental (ES)
- University at Buffalo, State University of New York (US)
- Venue
- Psychotherapy and Psychosomatics
- Publisher
- S. Karger AG
- Published
- 2016
- Volume
- 85
- Issue
- 5
- Pages
- 270-288
- ISSN
- 0033-3190 (ISSN-L)
- 1423-0348
- OpenAlex
- W2477696699
- Semantic Scholar
- 4af046d5cf1f48ed09514ffef416d2de5c0d29cf
- Cited by
- 650
- References
- 251
- Citations by year
- 2026: 46 · 2025: 67 · 2024: 95 · 2023: 84 · 2022: 81 · 2021: 75 · 2020: 55 · 2019: 54 · 2018: 50 · 2017: 38 · 2016: 4
- FWCI
- 5.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- karger.com/pages/terms-and-conditions (vor)
- karger.com/pages/terms-and-conditions (tdm)
- Locations
- Psychotherapy and Psychosomatics (publishedVersion)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- Funders
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Keywords
- newer antidepressants, antidepressant side effects, drug safety, tolerability, selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, bupropion, mirtazapine, trazodone, agomelatine, vilazodone, levomilnacipran, vortioxetine, gastrointestinal adverse effects, hepatotoxicity, weight gain, QT prolongation, sexual dysfunction, hyponatremia, osteoporosis, paradoxical effects, suicidality, antidepressant overdose, discontinuation syndrome, pregnancy and lactation, cancer risk, drug selection
- MeSH terms
- Antidepressive Agents, Major Depressive Disorder, Humans, Risk Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.